Concepedia

Ying-Qing Wang

YW

20

Publications

793

Citations

16

H-Index

2012

Active since

Affiliations

Shanghai Institute of Materia Medica(Current)

Chinese Academy of Sciences

University of Chinese Academy of Sciences

State Key Laboratory of Drug Research

Ying-Qing Wang is an author at Shanghai Institute of Materia Medica specializing in medicine, drug discovery, and pharmacology.

Top concepts

Publications per year

2012–2021

20

Publications

20

Fragment-Based Drug Discovery of 2-Thiazolidinones as Inhibitors of the Histone Reader BRD4 Bromodomain

Lele Zhao, Danyan Cao, Tiantian Chen et al. · Journal of Medicinal Chemistry · 2013 · 118 citations · Full text

, , +14

Natural Product Triptolide Mediates Cancer Cell Death by Triggering CDK7-Dependent Degradation of RNA Polymerase II

Stefano Giustino Manzo, Zhaoli Zhou, Ying-Qing Wang et al. · Cancer Research · 2012 · 108 citations · Full text

Dual targeting of microtubule and topoisomerase II by α-carboline derivative YCH337 for tumor proliferation and growth inhibition

Jun-Mei Yi, Xiaofei Zhang, Xia‐Juan Huan et al. · Oncotarget · 2015 · 51 citations · Full text

Structural Modification of Natural Product Tanshinone I Leading to Discovery of Novel Nitrogen-Enriched Derivatives with Enhanced Anticancer Profile and Improved Drug-like Properties

Chunyong Ding, Qian-Ting Tian, Jie Li et al. · Journal of Medicinal Chemistry · 2018 · 50 citations

Fragment-Based Drug Discovery of 2-Thiazolidinones as BRD4 Inhibitors: 2. Structure-Based Optimization

Lele Zhao, Ying-Qing Wang, Danyan Cao et al. · Journal of Medicinal Chemistry · 2015 · 49 citations · Full text

Rows per page

1–5 of 20